Nephroquiz 1: cyclophosphamide or mycofenolate mofetil?
نویسندگان
چکیده
CASE A 36-year-old man was admitted because of weakness, generalized edema, skin rash, and acute kidney failure with active urine sediment. Results of laboratory studies were as follows: blood leukocyte count, 14× 109/L; hemoglobin, 10 g/dL; blood platelet count, 145 × 109/L; blood urea nitrogen, 102 mg/dL; serum creatinine, 5.8 mg/dL; complement 3, 32 mg/ dL; complement 4, 3 mg/dL; serum hemolytic activity (CH50), 100 U/ mL; antinuclear antibody, 1/80; and anti-double-stranded-DNA, 1/20. On pathologic examination of the biopsy specimen from the kidney, 7 glomeruli were present, of which 1 was obsolete and others showed mesangial widening and endocapillary proliferation with neutrophilic infiltration, subendothelial hyaline deposits (wire loops), and intraluminal thrombi in some of them. Half of the glomeruli revealed cellular crescents (Figures 1 and 2). There was no spike formation. Activity index was 18/24 and chronicity index, 5/12. The fluorescent antibody technique study revealed a typically full-house pattern (Figure 3). About 40% of tubules were atrophic. Based on clinical presentation and laboratory and pathologic findings, diagnosis of diffuse proliferative lupus nephritis (class-IV-G, A/C) was established. IJKD 2009;3:112-3 www.ijkd.org
منابع مشابه
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment. Although many of these patients respond to immunosuppressive drugs such as intravenous cyclophosphamide (IVCY), azathioprine (AZA), mizoribine, tacrolimus, cyclosporine A (CSA) and mycofenolate mofetil (MMF), some remain refractory to such therapies. Recent studies of multi-t...
متن کاملChorea in systematic lupus erythematosus; a case report.
We report a 33-year-old female who developed a movement disorder during maintenance therapy for systemic lupus erythematosus (SLE). She was diagnosed with SLE at the age of 25, and experienced an episode of SLE-associated hemophagocytic syndrome at age 27, which was successfully treated with intensive immunosuppressive therapy. In November 2012, during maintenance therapy with prednisolone (PSL...
متن کاملDesensitization to Mycofenolate Mofetil: a novel 12 step protocol.
The use of MMF has become standard practice in many solid organ transplant recipients due its efficacy and favorable risk profile compared to other immunosuppressants. There has been a single case report of successful MMF desensitization. However, this protocol did not follow current Drug practice parameters. We report a successful desensitization to MMF in a double heart-kidney transplant reci...
متن کاملSevere sclerosing cholangitis after Langerhans cell histiocytosis treated by liver transplantation
BACKGROUND Langerhans cell histiocytosis (LCH) is a rare hematopoietic disorder of unknown pathogenesis. LCH diseases may occur in a single organ or multisystem organ. The patients with multisystem involvement usually have a poor prognosis. Liver involvement in multisystem LCH results in severe complications, such as obvious sclerosing cholangitis (SC) with jaundice. METHODS We reported a 31-...
متن کاملMycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
BACKGROUND AND OBJECTIVES Although the accepted standard of care for induction of lupus nephritis has been cyclophosphamide, recent trials suggest that mycophenolate mofetil may be as or more effective and less toxic. A systematic review and meta-analysis were performed to determine the risk for failure to induce remission of lupus nephritis in patients who were treated with mycophenolate mofet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Iranian journal of kidney diseases
دوره 3 2 شماره
صفحات -
تاریخ انتشار 2009